Literature DB >> 215232

Plasminogen activator from cells transformed by an oncogenic virus: inhibitors of the activation reaction.

K Danø, E Reich.   

Abstract

This paper describes an assay for direct measurement of plasminogen activation and its application for determining the kinetic constants and for screening potential inhibitors of the reaction. The assay is based on the conversion of the single chain of 125I-labelled plasminogen to the two chains of 125I-labelled plasmin (EC 3.4.21.7), the latter then being separated from each other and from the plasminogen substrate by electrophoresis under reducing conditions in SDS-polyacrylamide gels. The Km of activator from transformed murine cells for human plasminogen was 180 nM. A broad range of compounds was tested as potential inhibitors of plasminogen activation and of plasmin-catalyzed fibrinolysis respectively, and the two reactions differed qualitatively and quantitatively in their response to previous agents. The principal qualitative difference was in the susceptibility of the reactions to a spectrum of naturally-occurring macromolecular inhibitors: all of the macromolecular inhibitors that blocked the action of plasmin were without effect on murine activator or human urokinase (EC 3.4.99.26). A variety of small molecules inhibited both of the reactions tested, and showed significant quantitative differences; some of these were active at micron concentrations. The exacting specificity of plasminogen activators for macromolecules, both substrates and inhibitors, encourages the expectation that effective inhibitors of great specificity may be isolated from as yet undiscovered natural sources.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 215232     DOI: 10.1016/0005-2744(79)90256-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma.

Authors:  P Kristensen; C Pyke; L R Lund; P A Andreasen; K Danø
Journal:  Histochemistry       Date:  1990

Review 2.  Studies on rat mammary adenocarcinomas: a model for metastasis.

Authors:  I A Ramshaw; P Badenoch-Jones
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

3.  Evidence for an extracellular plasmin-dependent proteolytic system in mineralizing matrices.

Authors:  R M Robinson; R E Taylor; H Birkedal-Hansen
Journal:  Calcif Tissue Int       Date:  1984-01       Impact factor: 4.333

4.  A negative blood-clotting factor lining the vessels.

Authors:  E Heymann; R Mentlein
Journal:  Naturwissenschaften       Date:  1982-04

5.  Proteases released in organ culture by acute dermal inflammatory lesions produced in vivo in rabbit skin by sulfur mustard: hydrolysis of synthetic peptide substrates for trypsin-like and chymotrypsin-like enzymes.

Authors:  K Higuchi; A Kajiki; M Nakamura; S Harada; P J Pula; A L Scott; A M Dannenberg
Journal:  Inflammation       Date:  1988-08       Impact factor: 4.092

Review 6.  [Has dipeptidyl peptidase IV an effect on blood pressure and coagulation?].

Authors:  E Heymann; R Mentlein
Journal:  Klin Wochenschr       Date:  1984-01-02

7.  Cellular and secreted tumor plasminogen activator: the effects of NaCl.

Authors:  P Badenoch-Jones; I A Ramshaw; A Grant
Journal:  Experientia       Date:  1986-04-15

8.  Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody.

Authors:  P A Andreasen; L S Nielsen; J Grøndahl-Hansen; L Skriver; J Zeuthen; R W Stephens; K Danø
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598

9.  Tumor promoter PMA stimulates the synthesis and secretion of mouse pro-urokinase in MSV-transformed 3T3 cells: this is mediated by an increase in urokinase mRNA content.

Authors:  D Belin; F Godeau; J D Vassalli
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

10.  Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.

Authors:  D L Eaton; J B Baker
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.